Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NAD Augmentation to Treat Diabetes Kidney Disease: A Randomized Controlled Trial

NCT05759468 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT05759468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05759468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NAD Augmentation to Treat Diabetes Kidney Disease: A Randomized Controlled Trial
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
April 13, 2023
Completion date
March 31, 2027
Enrollment
156 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic kidney disease, type2diabetes